Cargando…

Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer

Cancer-associated fibroblasts (CAFs), a dominant component of the pancreatic tumor microenvironment, are mainly considered as promotors of malignant progression, but the underlying molecular mechanism remains unclear. Here, we show that SDF-1 secreted by CAFs stimulates malignant progression and gem...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Lusheng, Ye, Huilin, Li, Guolin, Lu, Yuanting, Zhou, Quanbo, Zheng, Shangyou, Lin, Qing, Liu, Yimin, Li, Zhihua, Chen, Rufu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194073/ https://www.ncbi.nlm.nih.gov/pubmed/30337520 http://dx.doi.org/10.1038/s41419-018-1104-x

Ejemplares similares

Correction: Cancer-associated fibroblasts promote progression and gemcitabine resistance via the SDF-1/SATB-1 pathway in pancreatic cancer
por: Wei, Lusheng, et al.
Publicado: (2021)

Tumor-associated macrophages promote progression and the Warburg effect via CCL18/NF-kB/VCAM-1 pathway in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018)

Cancer-associated fibroblasts-mediated ATF4 expression promotes malignancy and gemcitabine resistance in pancreatic cancer via the TGF-β1/SMAD2/3 pathway and ABCC1 transactivation
por: Wei, Lusheng, et al.
Publicado: (2021)

circFARP1 enables cancer-associated fibroblasts to promote gemcitabine resistance in pancreatic cancer via the LIF/STAT3 axis
por: Hu, Chonghui, et al.
Publicado: (2022)

FEZF1-AS1/miR-107/ZNF312B axis facilitates progression and Warburg effect in pancreatic ductal adenocarcinoma
por: Ye, Huilin, et al.
Publicado: (2018)

Endogenous miRNA Sponge LincRNA-ROR promotes proliferation, invasion and stem cell-like phenotype of pancreatic cancer cells
por: Fu, Zhiqiang, et al.
Publicado: (2017)

Cancer-associated fibroblast-induced lncRNA UPK1A-AS1 confers platinum resistance in pancreatic cancer via efficient double-strand break repair
por: Zhang, Xiang, et al.
Publicado: (2022)

The long non-coding RNA HOTTIP promotes progression and gemcitabine resistance by regulating HOXA13 in pancreatic cancer
por: Li, Zhihua, et al.
Publicado: (2015)

Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers
por: Wang, Yingxue, et al.
Publicado: (2015)

Gemcitabine Compared With Gemcitabine and S-1 Combination Therapy in Advanced Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Li, Doudou, et al.
Publicado: (2015)

circCUL2 induces an inflammatory CAF phenotype in pancreatic ductal adenocarcinoma via the activation of the MyD88-dependent NF-κB signaling pathway
por: Zheng, Shangyou, et al.
Publicado: (2022)

A novel gene signature for prognosis prediction and chemotherapy response in patients with pancreatic cancer
por: Lin, Hongcao, et al.
Publicado: (2021)

lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer
por: Ren, Xiaofan, et al.
Publicado: (2020)

Correction: lncRNA-PLACT1 sustains activation of NF-κB pathway through a positive feedback loop with IκBα/E2F1 axis in pancreatic cancer
por: Ren, Xiaofan, et al.
Publicado: (2022)

HIF‐2α regulates non‐canonical glutamine metabolism via activation of PI3K/mTORC2 pathway in human pancreatic ductal adenocarcinoma
por: Li, Wenzhu, et al.
Publicado: (2017)

Metabolic Phenotypes in Pancreatic Cancer
por: Yu, Min, et al.
Publicado: (2015)

Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy
por: Li, Doudou, et al.
Publicado: (2015)

Standard pancreatoduodenectomy versus extended pancreatoduodenectomy with modified retroperitoneal nerve resection in patients with pancreatic head cancer: a multicenter randomized controlled trial
por: Lin, Qing, et al.
Publicado: (2022)

Tumor-neuroglia interaction promotes pancreatic cancer metastasis
por: Su, Dan, et al.
Publicado: (2020)

Single-cell RNA sequencing reveals spatiotemporal heterogeneity and malignant progression in pancreatic neuroendocrine tumor
por: Zhou, Yu, et al.
Publicado: (2021)

HNF1A regulates oxaliplatin resistance in pancreatic cancer by targeting 53BP1
por: Xia, Renpeng, et al.
Publicado: (2023)

High expression of AFAP1-AS1 is associated with poor survival and short-term recurrence in pancreatic ductal adenocarcinoma
por: Ye, Yibiao, et al.
Publicado: (2015)

LncRNA HOTAIR epigenetically suppresses miR-122 expression in hepatocellular carcinoma via DNA methylation
por: Cheng, Di, et al.
Publicado: (2018)

Extracellular vesicle-packaged circBIRC6 from cancer-associated fibroblasts induce platinum resistance via SUMOylation modulation in pancreatic cancer
por: Zheng, Shangyou, et al.
Publicado: (2023)

SATB1 Promotes Pancreatic Cancer Growth and Invasion Depending on MYC Activation
por: Chen, Zheng, et al.
Publicado: (2015)

LLGL1 Regulates Gemcitabine Resistance by Modulating the ERK-SP1-OSMR Pathway in Pancreatic Ductal Adenocarcinoma
por: Zhu, Yin-Xin, et al.
Publicado: (2020)

The mRNA expression of SATB1 and SATB2 in human breast cancer
por: Patani, Neill, et al.
Publicado: (2009)

Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma
por: Elebro, Jacob, et al.
Publicado: (2014)

Macrophage migration inhibitory factor is overexpressed in pancreatic cancer tissues and impairs insulin secretion function of β-cell
por: Tan, Langping, et al.
Publicado: (2014)

Linc00511 acts as a competing endogenous RNA to regulate VEGFA expression through sponging hsa‐miR‐29b‐3p in pancreatic ductal adenocarcinoma
por: Zhao, Xiaohui, et al.
Publicado: (2017)

Divergent expression patterns of SATB1 mRNA and SATB1 protein in colorectal cancer and normal tissues
por: Kowalczyk, Anna E., et al.
Publicado: (2015)

SATB1 and SATB2 play opposing roles in c-Myc expression and progression of colorectal cancer
por: Mansour, Mohammed A., et al.
Publicado: (2015)

Gemcitabine plus S-1 for metastatic pancreatic cancer
por: Zhu, Hong, et al.
Publicado: (2018)

Cancer-associated fibroblasts promote the progression of endometrial cancer via the SDF-1/CXCR4 axis
por: Teng, Fei, et al.
Publicado: (2016)

SATB1 promotes epithelial-mesenchymal transition and metastasis in prostate cancer
por: Qi, Honggang, et al.
Publicado: (2017)

Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer()()()
por: Lee, Jiyoon, et al.
Publicado: (2016)

Fibroblast inhibition by tocilizumab enabled gemcitabine/nab‐paclitaxel rechallenge for pancreatic cancer
por: Mitsunaga, Shuichi, et al.
Publicado: (2023)

Expression of SATB1 Promotes the Growth and Metastasis of Colorectal Cancer
por: Zhang, Yi, et al.
Publicado: (2014)

Nanocomplexation of thrombin with cationic amylose derivative for improved stability and hemostatic efficacy
por: Zhuang, Baoxiong, et al.
Publicado: (2015)

LncRNA SATB2-AS1 inhibits tumor metastasis and affects the tumor immune cell microenvironment in colorectal cancer by regulating SATB2
por: Xu, Mu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0ge4v2r688nlfstguqlshli2d3